POCN Hem/Onc

Hem/Onc Roundup: Cancer’s Long-Term Impact, Lung Cancer Immunotherapy, and more

| Categories: hematology-oncology, pocn-hem-onc

Lung Cancer Patients with a Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy A new study shows that lung cancer patients with a […]

Hem/Onc Roundup: Cancer’s Long-Term Impact, Lung Cancer Immunotherapy, and more

POCNnews2020-11-25T14:58:32+00:00November 20th, 2020|Hematology & Oncology, POCN Hem/Onc|

Comments Off

Brian Jonas, MD, Discusses FDA Approval of Venclexta® in Combination for the Treatment of Newly Diagnosed AML

POCNnews2020-11-25T14:58:26+00:00November 20th, 2020|Acute Myeloid Leukemia Condition Center, Hematology & Oncology, POCN Hem/Onc|

Comments Off

CNS Pharmaceuticals Announces FDA Filing for Investigational New Drug to Treat Glioblastoma

POCNnews2020-11-25T14:58:25+00:00November 19th, 2020|Hematology & Oncology, POCN Hem/Onc|

Comments Off

Persistent Poverty Correlated with Increased Cancer Mortality

POCNnews2020-10-07T02:08:13+00:00September 30th, 2020|POCN Hem/Onc|

Comments Off